N Sussman

Summary

Publications

  1. ncbi request reprint Six-year perspectives on the safety and tolerability of nefazodone
    David L Dunner
    Department of Psychiatry and Behavioral Sciences, University of Washington, and Center for Anxiety and Depression, Seattle 98105 6099, USA
    J Clin Psychiatry 63:32-41. 2002
  2. ncbi request reprint Effects of nefazodone on body weight: a pooled analysis of selective serotonin reuptake inhibitor- and imipramine-controlled trials
    N Sussman
    Department of Psychiatry, New York University School of Medicine, NY 10155, USA
    J Clin Psychiatry 62:256-60. 2001
  3. ncbi request reprint Review of atypical antipsychotics and weight gain
    N Sussman
    Department of Psychiatry, New York University School of Medicine, New York 10016, USA
    J Clin Psychiatry 62:5-12. 2001
  4. ncbi request reprint Interpreting antidepressant clinical trials
    Norman Sussman
    NYU School of Medicine, New York, NY 10016, USA
    Ann Clin Psychiatry 19:215-20. 2007
  5. ncbi request reprint Choosing an atypical antipsychotic
    Norman Sussman
    New York University School of Medicine, New York, USA
    Int Clin Psychopharmacol 17:S29-33. 2002
  6. ncbi request reprint Rates of remission/euthymia with quetiapine in combination with lithium/divalproex for the treatment of acute mania
    Norman Sussman
    New York University School of Medicine, New York, New York 10155, USA
    J Affect Disord 100:S55-63. 2007
  7. ncbi request reprint Venlafaxine XR therapy for major depression and anxiety disorders. The clinical implications that its advantages pose
    N Sussman
    New York University School of Medicine, New York, USA
    Postgrad Med 106:31-6. 1999
  8. ncbi request reprint The implications of weight changes with antipsychotic treatment
    Norman Sussman
    Department of Psychiatry, New York University School of Medicine, New York, NY 10016, USA
    J Clin Psychopharmacol 23:S21-6. 2003
  9. ncbi request reprint A 4-step program for the diagnosis and management of depression
    C Brendan Montano
    Department of Family Practice, University of Connecticut Medical School, Cromwell, CT USA
    J Fam Pract . 2003
  10. ncbi request reprint Treatment regimens for managing depression in family practice
    Adam Keller Ashton
    SUNY at Buffalo School of Medicine, Buffalo, NY, USA
    J Fam Pract . 2003

Collaborators

  • D L Dunner
  • Adam Keller Ashton
  • Jaye Hefner
  • C Brendan Montano
  • Bertrand Winsberg
  • Bezalel Dantz
  • Dale A D'Mello
  • F George Leon
  • Gary A Matson
  • James F Pradko

Detail Information

Publications13

  1. ncbi request reprint Six-year perspectives on the safety and tolerability of nefazodone
    David L Dunner
    Department of Psychiatry and Behavioral Sciences, University of Washington, and Center for Anxiety and Depression, Seattle 98105 6099, USA
    J Clin Psychiatry 63:32-41. 2002
  2. ncbi request reprint Effects of nefazodone on body weight: a pooled analysis of selective serotonin reuptake inhibitor- and imipramine-controlled trials
    N Sussman
    Department of Psychiatry, New York University School of Medicine, NY 10155, USA
    J Clin Psychiatry 62:256-60. 2001
    ..To determine if differences exist among the newer antidepressants, the authors retrospectively analyzed data from clinical trials comparing nefazodone with SSRIs and with imipramine...
  3. ncbi request reprint Review of atypical antipsychotics and weight gain
    N Sussman
    Department of Psychiatry, New York University School of Medicine, New York 10016, USA
    J Clin Psychiatry 62:5-12. 2001
    ..Such complete information and multidimensional analysis would minimize obfuscation about the true nature of a drug's impact on body weight...
  4. ncbi request reprint Interpreting antidepressant clinical trials
    Norman Sussman
    NYU School of Medicine, New York, NY 10016, USA
    Ann Clin Psychiatry 19:215-20. 2007
    ..Psychiatrists and other clinicians make decisions about antidepressant medications with little understanding on how to interpret the research literature...
  5. ncbi request reprint Choosing an atypical antipsychotic
    Norman Sussman
    New York University School of Medicine, New York, USA
    Int Clin Psychopharmacol 17:S29-33. 2002
    ....
  6. ncbi request reprint Rates of remission/euthymia with quetiapine in combination with lithium/divalproex for the treatment of acute mania
    Norman Sussman
    New York University School of Medicine, New York, New York 10155, USA
    J Affect Disord 100:S55-63. 2007
    ..The aim of this analysis was to compare the rates of remission/euthymia in patients with bipolar mania receiving quetiapine in combination with lithium/divalproex (QTP+Li/DVP) versus placebo (PBO) in combination with Li/DVP (PBO+Li/DVP)...
  7. ncbi request reprint Venlafaxine XR therapy for major depression and anxiety disorders. The clinical implications that its advantages pose
    N Sussman
    New York University School of Medicine, New York, USA
    Postgrad Med 106:31-6. 1999
    ..These advantages make venlafaxine XR an important option for the treatment of major depression and anxiety disorders...
  8. ncbi request reprint The implications of weight changes with antipsychotic treatment
    Norman Sussman
    Department of Psychiatry, New York University School of Medicine, New York, NY 10016, USA
    J Clin Psychopharmacol 23:S21-6. 2003
    ..Furthermore, these drugs have efficacy for treating other conditions such as bipolar disorder. Physicians prescribing atypical antipsychotics must be aware of the risk of weight gain and its associated comorbidities...
  9. ncbi request reprint A 4-step program for the diagnosis and management of depression
    C Brendan Montano
    Department of Family Practice, University of Connecticut Medical School, Cromwell, CT USA
    J Fam Pract . 2003
  10. ncbi request reprint Treatment regimens for managing depression in family practice
    Adam Keller Ashton
    SUNY at Buffalo School of Medicine, Buffalo, NY, USA
    J Fam Pract . 2003
  11. ncbi request reprint Response to treatment: gaining and maintaining remission from depression
    Jaye Hefner
    University of Pittsburgh Medical Center, Pittsburgh, PA, USA
    J Fam Pract . 2003
  12. ncbi request reprint Depression--augmentation or switch after initial SSRI treatment
    Norman Sussman
    N Engl J Med 354:2611-3; author reply 2611-3. 2006
  13. ncbi request reprint Applying neuropharmacy when treating patients with depression
    Adam Keller Ashton
    SUNY at Buffalo School of Medicine, Buffalo, NY USA
    J Fam Pract . 2003